🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Alvotech

ALVO Healthcare
$3.65 +$0.03 (0.83%)
Market Cap: $1.14 B
Gurus Holding
3
Popularity Rank
#2998
% of Shares Held
0.18%
Net Activity (Q4 2025)
-$4.88 M

Guru Ownership Trend

Guru Analysis for Alvotech (ALVO)

Alvotech (ALVO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.1 M.

Top institutional holders include Howard Marks and Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.88 M net outflow during the quarter.

Recent activity highlights Steven Cohen who opened a new position. Conversely, Howard Marks reduced exposure by 65.9%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$76,129
Total Buy Value
New Buys 1
Additions 0
-$4.96 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for Alvotech (ALVO)

Major holders include Howard Marks ($2.02 M), Renaissance Technologies (RenTech) ($131,328), Steven Cohen ($76,129). According to the latest reported data, 3 tracked investment managers collectively hold approximately 574,096 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.88 M, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ALVO. The total reported sell value was $4.96 M.

Yes, 1 managers opened new positions in ALVO, and 0 increased their existing holdings. The total reported buy value was $76,129.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% Reduce -65.9% 533,656 $2.02 M Q4 2025
0.00% Reduce -20.4% 25,600 $131,328 Q4 2025
0.00% New Buy 14,840 $76,129 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form